Acquired Camptodactyly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Congenital kyphoscoliosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Telecanthus
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Advanced bone age
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Global developmental delay
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Kyphoscoliosis deformity of spine
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Acquired Kyphoscoliosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Congenital Camptodactyly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Full cheeks
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Neonatal Hypotonia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Premature aging syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Aberrant Function of the C-Terminal Tail of HIST1H1E Accelerates Cellular Senescence and Causes Premature Aging.
|
31447100 |
2019 |
Autistic Disorder
|
0.010 |
Biomarker
|
disease |
BEFREE |
While the mechanism of how haploinsufficiency of HIST1H1E causes autism is entirely unknown, our report underscores the importance of further study of the function of this protein and other histone linker proteins in brain development.
|
29704315 |
2018 |
Pervasive Development Disorder
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Epigenetics and autism spectrum disorder: A report of an autism case with mutation in H1 linker histone HIST1H1E and literature review.
|
29704315 |
2018 |
Autism Spectrum Disorders
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Epigenetics and autism spectrum disorder: A report of an autism case with mutation in H1 linker histone HIST1H1E and literature review.
|
29704315 |
2018 |
Overgrowth Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
The physical features of the proposita were essentially the same as those observed in patients with the aforementioned HIST1H1E-related overgrowth syndrome.
|
29383847 |
2018 |
Developmental Disabilities
|
0.010 |
Biomarker
|
group |
BEFREE |
This includes HIST1H1E, encoding histone H1.4, which has not been associated with a developmental disorder previously.
|
28475857 |
2017 |
Non-obstructive azoospermia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We identified three low-frequency variants located at 6p22.2 (rs2298090 in HIST1H1E encoding p.Lys152Arg: OR = 0.30, P = 2.40 × 10(-16)) and 6p21.33 (rs200847762 in FKBPL encoding p.Pro137Leu: OR = 0.11, P = 3.77 × 10(-16); rs11754464 in MSH5: OR = 1.78, P = 3.71 × 10(-7)) associated with NOA risk after Bonferroni correction.
|
26199320 |
2015 |
Hyperactive behavior
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
In addition, these LMW isoforms are biochemically hyperactive, shown by their ability to phosphorylate substrates such as histone H1 4 fold more in cells transfected with T1 or T2 versus cells transfected with the full length form.
|
12963845 |
2004 |
Pancreatic carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results indicate that the AC inhibitor in the pancreatic cancer extract is histone H1b or H1d and histones H2A, H2B and H3 also have an AC inhibitory activity.
|
2018521 |
1991 |
Malignant neoplasm of pancreas
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results indicate that the AC inhibitor in the pancreatic cancer extract is histone H1b or H1d and histones H2A, H2B and H3 also have an AC inhibitory activity.
|
2018521 |
1991 |